五洲医疗 (301234.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

CNY 7.48B

MomentumView details →

1D Return

+14.46%

YTD Return

+151.76%

RSI (14)

67.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

CNY 7.48B

RSI (14)

67.5

MomentumView details →

1D Return

+14.46%

YTD Return

+151.76%

ProfitabilityView details →

Gross Margin

15.20%

Net Margin

4.69%

EBITDA Margin

13.60%

ROE (TTM)

2.77%

ROA (TTM)

2.50%

Asset Turnover

0.53x

GrowthView details →

Revenue YoY

−7.46%

EPS YoY

−40.35%

FCF YoY

+18.98%

Revenue CAGR 3Y

−5.73%

EPS CAGR 3Y

−38.46%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

8.08x

Quick Ratio

7.46x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

454.82M

Net Income (TTM)

21.31M

Op. CF (TTM)

60.76M

Latest newsMore news →

Wuzhou Medical announced its first-half 2026 results: revenue of 203 million yuan, down 6.40% year-on-year; net profit attributable to shareholders of 15.3634 million yuan, up 46.11% year-on-year; non-GAAP net profit of 10.9049 million yuan, up 30.77% year-on-year.13d ago

Wuzhou Medical announced that shareholders including Huang Fan signed a supplementary agreement with transferee Jiaxing Huixin and its controller Cao Yong, adjusting only the final installment payment terms of the original share transfer agreement, with the total transfer of 8.0288 million shares (11.8071% of total share capital) for 390 million yuan unchanged.16d ago

Similar companies

仁和药业000650.SZ 中天火箭003009.SZ 天宇股份300702.SZ 亿道信息001314.SZ 万孚生物300482.SZ 川润股份002272.SZ

Latest newsMore news →

Wuzhou Medical announced its first-half 2026 results: revenue of 203 million yuan, down 6.40% year-on-year; net profit attributable to shareholders of 15.3634 million yuan, up 46.11% year-on-year; non-GAAP net profit of 10.9049 million yuan, up 30.77% year-on-year.13d ago Wuzhou Medical announced that shareholders including Huang Fan signed a supplementary agreement with transferee Jiaxing Huixin and its controller Cao Yong, adjusting only the final installment payment terms of the original share transfer agreement, with the total transfer of 8.0288 million shares (11.8071% of total share capital) for 390 million yuan unchanged.16d ago